Destiny-Pharma
2 known investors
AMR Bio is a clinical-stage biotechnology company developing novel anti-infectives, with a focus on infection prevention. Its work includes a pipeline of anti-infective candidates aimed at combating antibiotic-resistant infections.
Investors Β· 2
Frequently asked questions
- What does Destiny-Pharma do?
- AMR Bio is a clinical-stage biotechnology company developing novel anti-infectives, with a focus on infection prevention. Its work includes a pipeline of anti-infective candidates aimed at combating antibiotic-resistant infections.
- Who are Destiny-Pharma's investors?
- Destiny-Pharma's investors include Juno Capital Partners, Seneca Partners.